Agios Pharmaceuticals | AGIO - Ebit

股票价格
25.32
每天变化
-0.42 -1.63%
每月一次
-14.43%
每年
-14.02%
Q2 预测
24.78


金融业
股票价格
USD
资产
USD 1.3B
现金及等价物
USD 89.13M
销售成本
USD 1.88M
流动资产
USD 942.05M
流动负债
USD 82.21M
债务
USD 44.52M
EBIT
USD -121.58M
EBITDA
USD -115.5M
员工
486
EPS每股收益
USD -1.86
股本和储备
USD 1.19B
销售毛利
USD 18.09M
债务利息支出
USD 1.39B
利息收入
USD 13.37M
贷款资金
USD 1.06M
市值
USD 1.44B
净收入
USD -108.04M
营业费用
USD 141.55M
营业利润
USD -121.58M
普通股股本
USD 58.45M
PE价格收益
3.56
税前利润
USD -109.06M
销售收入
USD 19.97M
销售和管理费用
USD 42.97M
股票
USD 32.92M
贸易债权人
USD 18.36M
应收帐款人
USD 10.58M


Ebit 更改 日
AbbVie USD 5.81B 4.36B 2025-12
Agios Pharmaceuticals USD -121.58M 4.71M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
Amgen USD 3.96B 464M 2025-12
Arrowhead Research USD 40.81M 17.01M 2025-12
Astellas Pharma JPY 134.54B 30.13B 2025-12
AstraZeneca USD 2.97B 4.48B 2025-12
Bayer EUR 1.11B 1.51B 2025-12
Biogen USD 659.6M 157M 2025-09
BioMarin Pharmaceutical USD 198.39M 230.08M 2025-12
Bristol-Myers Squibb USD 3.47B 567M 2025-12
Daiichi Sankyo JPY 89.54B 42.01B 2025-12
Eli Lilly USD 8.99B 1.57B 2025-12
Exelixis USD 235.91M 20.45M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Incyte USD 383.88M 47.44M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
Merck USD 6.24B 1.32B 2025-12
Moderna USD -857M 597M 2025-12
Nektar Therapeutics USD -19.09M 15.26M 2025-12
Novartis USD 4.06B 530M 2025-12
Novartis USD 4.06B 413M 2025-12
Pfizer USD 4.65B 71M 2025-12
Puma Biotechnology USD -2.2M 11.41M 2024-06
Regeneron Pharmaceuticals USD 898.6M 211.3M 2025-12
Roche Holding CHF 9.56B 2.1B 2025-12
Sarepta Therapeutics USD -410.08M 347.2M 2025-12
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12